At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 6 enrolled
Drug / intervention
Zoledronic Acid +2 moredrug
Likely dose
Zoledronic Acid 5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study for Zoledronic Acid to Prevent High-Turnover Bone Loss After Bariatric Surgery
In Brief
A Phase 4 clinical trial evaluating Zoledronic Acid, Calcium citrate + vitamin D, and 1 other intervention for Bariatric Surgery Candidate. Completed, enrolled 6 participants across 1 site.
Detailed Summary
This study evaluates whether zoledronic acid can prevent the high bone turnover that occurs after Roux-en-Y Gastric Bypass (RYGB) and sleeve gastrectomy (SG) surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBariatric Surgery Candidate
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedFeb 2018
Enrollment StartAug 2018
Primary CompletionJan 2020
TodayJul 2026
First PostedFeb 6, 2018
Enrollment StartAug 1, 2018
Primary CompletionJan 1, 2020
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 8.4 years ago
Interventions
Zoledronic Aciddrug
5mg zoledronic acid
Calcium citrate + vitamin Ddietary
Chewable 500mg calcium citrate with 500 International Units (IU) Vitamin D3
Vitamin D3dietary
1000IU Vitamin D3 gummy